Structure and Biosynthesis of Heat-Stable Antifungal Factor (HSAF), a Broad-Spectrum Antimycotic with a Novel Mode of Action

Authors

Fengan Yu, Aureogen Biosciences, Inc.
Kathia Zaleta-River, University of Nebraska - Lincoln
Xiangcheng Zhu, University of Nebraska - Lincoln
Justin Huffman, University of Nebraska - Lincoln
Jeffrey C. Millet, University of Nebraska - Lincoln
Steven D. Harris, University of Nebraska-LincolnFollow
Gary Y. Yuen, University of Nebraska - LincolnFollow
Xing-Cong Li, The University of Mississippi
Liangcheng Du, University of Nebraska - LincolnFollow

Document Type

Article

Date of this Version

2007

Citation

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 2007, p. 64–72

Comments

Copyright © 2007, American Society for Microbiology.

doi:10.1128/AAC.00931-06

Abstract

A screen for antifungal compounds from Lysobacter enzymogenes strain C3, a bacterial biological control agent of fungal diseases, has previously led to the isolation of heat-stable antifungal factor (HSAF). HSAF exhibits inhibitory activities against a wide range of fungal species and shows a novel mode of antifungal action by disrupting the biosynthesis of a distinct group of sphingolipids. We have now determined the chemical structure of HSAF, which is identical to that of dihydromaltophilin, an antifungal metabolite with a unique macrocyclic lactam system containing a tetramic acid moiety and a 5,5,6-tricyclic skeleton. We have also identified the genetic locus responsible for the biosynthesis of HSAF in strain C3. DNA sequencing of this locus revealed genes for a hybrid polyketide synthase-nonribosomal peptide synthetase (PKS-NRPS), a sterol desaturase, a ferredoxin reductase, and an arginase. The disruption of the PKS-NRPS gene generated C3 mutants that lost the ability to produce HSAF and to inhibit fungal growth, demonstrating a hybrid PKS-NRPS that catalyzed the biosynthesis of the unique macrolactam system that is found in many biologically active natural products isolated from marine organisms. In addition, we have generated mutants with disrupted sterol desaturase, ferredoxin reductase, and arginase and examined the metabolites produced in these mutants. The work represents the first study of the genetic basis for the biosynthesis of the tetramic acid-containing macrolactams. The elucidation of the chemical structure of HSAF and the identification of the genetic locus for its biosynthesis establish the foundation for future exploitation of this group of compounds as new fungicides or antifungal drugs.